Sign in
Enrolling by invitationNo phase

Airway Rod Device to Guide Breathing Tube Placement in Adults With Obesity

Tests a stabilizing rod device to help place a breathing tube in adults with obesity.

Key facts

Who runs it
Baylor College of Medicine
Where
Houston, United StatesSee the site
Trial code
Registry title
Utilization of Airway Stabilizing Rod to Assist With Laryngeal Mask Airway Guided Fiberoptic Intubation in Adults With Obesity
Status
Enrolling by invitation
People taking part
20 people, planned
Started
21 Apr 2025
Planned end
1 Sept 2025
Type of study
Interventional
Treatments tested
  • Fiberoptic Assisted Endotracheal Rod Intubation
Record updated
14 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obesity (BMI over 35) who are having planned surgery that needs a breathing tube. It tests a rod that helps place the tube through a laryngeal mask.

Age
18 years and older
Sex
All sexes can join.
Disease stage
BMI above 35 kg/m2.

Main reasons for not taking part

  • Pregnant women
  • Newborns
  • Children
  • People in prison
  • People who refuse to take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult (18-64 yrs),
  • Geriatric (65+ yrs)
  • BMI > 35 kg/m2
  • elective surgery requiring intubation

Who cannot take part

  • pregnant woman
  • neonates
  • children
  • incarcerated patient
  • patient refusal

Where in United States

  • Ben Taub General HospitalHouston, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The FASTER stabilizing rod offers the distinct advantage of intubating through the laryngeal mask airway with a fiberoptic scope via the FASTER stabilizing rod. The device allows for the provider to insert the endotracheal tube (ETT) with visual confirmation using the fiberoptic scope into the trachea. The device then allows for the laryngeal mask airway to be removed while stabilizing the ETT to ensure the ETT does not get dislodged.

Read full original descriptionShow less

The purpose of this protocol is to clinically test the validated prototype that the investigators have built and previously tested in adults with obesity.

The primary aims are to evaluate 1) the time to intubation and 2) the number of intubation attempts. The secondary aim is to note any complications from time to intubation to PACU discharge.

These complications include: Hypoxemia (10% decrease from baseline for 45 seconds)1 Airway trauma (minor) Esophageal intubation Laryngospasm Bronchospasm Oro-pharyngeal bleeding Arrythmia Emesis Epistaxis Dental damage Post-operative sore throat Post-operative hoarseness Accidental extubation during removal of the LMA.

The group in the trial

  • Morbid ObesityTreatment being tested

    Elective surgery requiring intubation, Age \> 18, BMI \> 35 kg/m2

    Treatment: Fiberoptic Assisted Endotracheal Rod Intubation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Utilization of Airway Stabilizing Rod to Assist With Laryngeal Mask Airway Guided Fiberoptic Intubation in Adults With Obesity
Plain-language title
Airway Rod Device to Guide Breathing Tube Placement in Adults With ObesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
14 May 2025